Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


STOCKWATCH: BGI-Shenzhen and Illumina in tug of war over Complete Genomics

This article was originally published in Clinica

Executive Summary

In the past few days it has become clear that the original $118 million bid for Californian genome sequencing firm Complete Genomics by China's BGI-Shenzhen was trumped by a $124 million bid from another US sequencing technology company Illumina. China's BGI-Shenzhen agreed to buy Complete Genomics in September (, 18 September 2012); the latter has been looking for a buyer since early June.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts